Skip to main content

Table 3 Characteristics of the RECs across the various European countries involved in GenOSept

From: Methodological challenges in European ethics approvals for a genetic epidemiology study in critically ill patients: the GenOSept experience

Characteristic

Median (IQR) or n (%)

[Range]

No of ICUs per country

7 (2–15)

[1–28]

Countries with centralized (national/regional) REC only

8 (44.4%)

Countries with local REC only

7 (38.9%)

Countries with both centralized and local REC

3 (16.7%)

Countries with paper application process

17 (94.4%)

Countries with online application process

1 (5.6%)

Medical members of REC

18 (100%)

Lay and Legal members of REC

13 (72.2%)

Lay but no Legal members of REC

1 (5.6%)

Approval at all units within country

14 (77.8%)

Approval at some units within country

3 (16.7%)

No approval at country

1 (5.6%)

Application process duration (months)

1.5 (1–7)

[1–24]

Additional information or modification required

7 (38.9%)

Countries with National guidelines for research in critical care

9 (50%)

  1. IQR inter-quartile range, n absolute number, % percentage